Product Images Rebif

The text appears to be a graph that shows the proportion of patients who had progression over a certain number of years for a placebo group and two treatment groups (Rebif 44). The graph shows that both Rebif 44 treatment groups had a statistically significant lower proportion of patients with progression compared to the placebo group. The lower dose of Rebif 44 had a higher p-value (0.04) compared to the higher dose (0.01).*

The text is not-available.*

The text describes the components of an injector, including the injector button and body, the dose label area, the syringe plunger, a transparent syringe housing, and a needle cap that contains a needle shield. This information may be helpful for understanding or troubleshooting issues with the injector.*

The text describes a Titration Pack for the medication %?ebif‘E (interferon beta-1a) for subcutaneous injection. The pack includes six single-use prefilled syringes in two different strengths: 8.8 mcg/0.2 mL and 22 mcg/0.5 mL. A medication guide for patients is included. The National Drug Code (NDC) is 44087-8822-1. The last line appears to be non-English characters and cannot be evaluated.*

This is a medication called "yArebif Rebidose" which is an injection containing interferon beta-1a. The Titration Pack comes in two dosages, 22mcg and 0.5mL. The medication is given through subcutaneous injection and comes with a Medication Guide that must be given to each patient. The package contains 6 single-use autoinjectors of 8.8 mcg / 0.2 mL and 6 single-use autoinjectors of 22 mcg / 0.5 mL. NDC code for this is 44087-0188-1. This medication requires a prescription from a healthcare professional.*

AReDif is a medication that contains interferon beta-1a and is administered via subcutaneous injection. The box contains 12 prefilled syringes, each with a capacity of 0.5 mL and a concentration of 22 meg. The medication is only available with a prescription and comes with a guide for patients. The NDC code for the product is 44087-0022-3.*

This is a medication containing interferon beta-1a, which is intended for subcutaneous injection. It comes in a package containing 12 single-use prefilled syringes and is available only by prescription. The enclosed medication guide is provided for patient information. The NDC number is 44087-0044-3.*

Arebif® Rebidose® is an injection of interferon beta-1a provided in 12 single-use autoinjectors with a volume of 0.5 mL and a concentration of 22 μg/0.5 mL. It is intended for subcutaneous injection. A medication guide is enclosed and must be given to each patient by the pharmacist.*